Share

Trump's week in review: Pres. Erdogan meeting, Tylenol warning and TikTok

By Ryan Foley, Christian Post Reporter
U.S. Health and Human Services Secretary Robert F. Kennedy Jr., joined by President Donald Trump (L), delivers an announcement on “significant medical and scientific findings for America’s children” in the Roosevelt Room of the White House on Sept. 22, 2025, in Washington, D.C. Federal health officials suggested a link between the use of acetaminophen during pregnancy as a risk for autism, although many health agencies have noted inconclusive results in the research.
U.S. Health and Human Services Secretary Robert F. Kennedy Jr., joined by President Donald Trump (L), delivers an announcement on “significant medical and scientific findings for America’s children” in the Roosevelt Room of the White House on Sept. 22, 2025, in Washington, D.C. Federal health officials suggested a link between the use of acetaminophen during pregnancy as a risk for autism, although many health agencies have noted inconclusive results in the research. | Andrew Harnik/Getty Images
1. Press conference on autism research

On Monday, the White House held a press conference alleging a link between autism and Tylenol use during pregnancy. While Trump bluntly urged women not to take Tylenol during pregnancy, the Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz clarified during an appearance on Fox News Tuesday that “The message is not, ‘Never take Tylenol’” but rather “Take Tylenol judiciously.” 

“We know that people who take Tylenol for prolonged periods of time during pregnancy seem to have a higher incidence of autism in aggregate,” he added. “Make sure there’s an important reason to take it. Don’t take it willy-nilly because you think it’s so safe it couldn’t possibly cause a problem, because those assumptions appear to be erroneous.” 

The White House released a fact sheet identifying the administration’s findings about the link between autism and Tylenol use during pregnancy as consistent with research from Johns Hopkins University and Harvard University that concluded there is a connection between Tylenol use and neurodevelopmental disorders in children. 

The White House press conference drew pushback from the World Health Organization, which maintained that “no consistent association has been established” between Tylenol use during pregnancy and autism. Kenvue, the manufacturer of Tylenol, released a statement indicating that it was “deeply concerned with the health risk this poses for expecting mothers and parents.”

Kenvue’s statement this week offered a noticeable contrast to a 2017 message posted on Tylenol’s X account, warning: “We actually don’t recommend using any of our products while pregnant.”

Ryan Foley is a reporter for The Christian Post. He can be reached at: ryan.foley@christianpost.com

You’ve readarticles in the last 30 days.

Was this article helpful?

Help keep The Christian Post free for everyone.

Our work is made possible by the generosity of supporters like you. Your contributions empower us to continue breaking stories that matter, providing clarity from a biblical worldview, and standing for truth in an era of competing narratives.

By making a recurring donation or a one-time donation of any amount, you’re helping to keep CP’s articles free and accessible for everyone.

We’re sorry to hear that.

Hope you’ll give us another try and check out some other articles. Return to homepage.

Most Popular

More Articles